| GATTEX/REVESTIVE | A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome | Phase 3 | Active not recruiting | 13 | Feb 10, 2027 |
| Zasocitinib (Dose A) | A Study of Zasocitinib in Adults With Hidradenitis Suppurativa | Phase 2 | Active not recruiting | 91 | Feb 5, 2027 |
| TAK-788 | A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer | Phase 2 | Completed | 324 | Sep 29, 2026 |
| TAK-788 | TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations | Phase 3 | Completed | 354 | Sep 22, 2026 |
| Tetravalent Dengue Vaccine (TDV) | A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults | Phase 3 | Active not recruiting | 496 | Aug 30, 2026 |
| Adenuric | Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration | Phase 3 | Completed | 9 | Aug 10, 2026 |
| LIVTENCITY | A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections | Phase 3 | Completed | 20 | Jul 22, 2026 |
| Dexlansoprazole | A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old | Phase 2 | Completed | 71 | Jul 21, 2026 |
| Brigatinib | Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping | Phase 2 | Completed | 118 | May 30, 2026 |
| TAK-279 | A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis | Phase 3 | Active not recruiting | 1,950 | May 7, 2026 |
| Zasocitinib | A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis | Phase 3 | Completed | 606 | Apr 22, 2026 |
| Ponatinib | A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia | Phase 2 | Terminated | 4 | Apr 21, 2026 |
| VONVENDI | A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) | Phase 3 | Completed | 47 | Apr 17, 2026 |
| ADZYNMA | A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) | Phase 2 | Completed | 29 | Apr 16, 2026 |
| Dexlansoprazole | A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old | Phase 2 | Terminated | 24 | Apr 13, 2026 |
| Budesonide | Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration Syndrome | Phase 3 | Completed | 60 | Apr 1, 2026 |
| Dazostinag | A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors | Phase 2 | Completed · results | 248 | Mar 30, 2026 |
| HGT-1110 | An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy | Phase 2 | Completed | 24 | Feb 13, 2026 |
| TAK-881 | A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases | Phase 3 | Completed · results | 65 | Jan 20, 2026 |
| TAK-101 | Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet | Phase 2 | Completed · results | 102 | Dec 9, 2025 |
| TAK-771 | A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants | Phase 3 | Completed · results | 15 | Oct 30, 2025 |
| TAK-771 | A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) | Phase 3 | Completed · results | 26 | Oct 28, 2025 |
| TAK-279 | A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis | Phase 3 | Completed · results | 18 | Oct 17, 2025 |
| Pioglitazone | Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention | Phase 2 | Completed | 61 | Sep 26, 2025 |
| Soticlestat | A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome | Phase 3 | Terminated · results | 352 | Sep 24, 2025 |
| Ponatinib | PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISIS | Phase 2 | Completed | 32 | Aug 31, 2025 |
| GDX012 | A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia | Phase 2 | Terminated · results | 16 | Aug 20, 2025 |
| Soticlestat | A Study of Soticlestat in Adults and Children With Rare Epilepsies | Phase 2 | Terminated · results | 156 | Jul 30, 2025 |
| TAK-341 | A Study of TAK-341 in Treatment of Multiple System Atrophy | Phase 2 | Completed · results | 158 | Jul 28, 2025 |
| TAK-280 | First-in-Human Study of TAK-280 in Participants With Solid Tumors | Phase 2 | Terminated · results | 69 | Jul 28, 2025 |
| ENTYVIO | A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) | Phase 3 | Completed · results | 121 | Jul 1, 2025 |
| TAK-186 | A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer | Phase 2 | Terminated · results | 95 | Jun 17, 2025 |
| TRINTELLIX | Postoperative Pain Management Following Laparoscopic Cholecystectomy | Phase 3 | Completed | 86 | Jun 7, 2025 |
| ORZEYFUL | A Study of TAK-861 in People With Narcolepsy Type 1 | Phase 3 | Completed · results | 105 | Jun 4, 2025 |
| ORZEYFUL | A Study of TAK-861 for the Treatment of Narcolepsy Type 1 | Phase 3 | Completed · results | 168 | Jun 3, 2025 |
| TDV | A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India | Phase 3 | Completed · results | 480 | May 5, 2025 |
| ENTYVIO | Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) | Phase 2 | Completed · results | 59 | Apr 3, 2025 |
| Soticlestat | A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine | Phase 3 | Terminated · results | 1 | Aug 14, 2024 |
| Lanthanum Carbonate | Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis | Phase 3 | Completed | 54 | Aug 10, 2024 |
| Takeda's Dengue Tetravalent Vaccine (Live, Attenuated) (TDV) | Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose | Phase 3 | Completed · results | 365 | May 25, 2024 |